Literature DB >> 8919493

Measures of psychiatric symptoms in Alzheimer patients: a review.

M F Weiner1, E Koss, K V Wild, D G Folks, P Tariot, H Luszczynska, P Whitehouse.   

Abstract

This review of instruments for the identification and quantification of psychiatric symptoms in Alzheimer disease (AD) is intended as a reference source for clinicians and researchers concerned with evaluating, quantifying, and managing psychiatric symptoms in AD. We review 16 clinician- and caregiver-rated scales selected from >30 scales on the basis of their face validity, their psychometric properties, the frequency of their use, and their promise as assessment instruments. Instruments are described in terms of the population on which they were developed, the symptoms assessed, informant, by whom administered, time to administer, time interval covered, number of items, measurement of frequency and severity, assessment of impact on caregiver, reliability, validity, and scoring. Recommendations are made concerning the best use of each scale. We summarize in table form the sources of information for instruments, characteristics of the instruments by domain, and potential use of instruments for quantification or management of symptoms and for estimation of caregiver burden. There are a number of reliable and valid scales for the assessment of psychiatric symptoms in AD, each with specific assets and liabilities. Knowledge of the specifics of these scales will enable clinicians and researchers to select the best instruments for their particular needs and to design more effective instruments.

Entities:  

Mesh:

Year:  1996        PMID: 8919493

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  11 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 2.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease.

Authors:  Jihye Choi; Ho-Won Lee; Kyoungho Suk
Journal:  J Neurol       Date:  2011-05-12       Impact factor: 4.849

4.  Instruments to measure behavioural and psychological symptoms of dementia.

Authors:  Rianne M van der Linde; Blossom C M Stephan; Tom Dening; Carol Brayne
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-05       Impact factor: 4.035

5.  Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease.

Authors:  R E Tractenberg; A Gamst; M F Weiner; E Koss; R G Thomas; L Teri; L Thal
Journal:  Int J Geriatr Psychiatry       Date:  2001-09       Impact factor: 3.485

Review 6.  A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impact.

Authors:  M D Walker; S S Salek; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

7.  Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Marian B Patterson; Linda Teri; Leon J Thal
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-06       Impact factor: 2.680

8.  Targeting Functional Decline in Alzheimer Disease: A Randomized Trial.

Authors:  Christopher M Callahan; Malaz A Boustani; Arlene A Schmid; Michael A LaMantia; Mary G Austrom; Douglas K Miller; Sujuan Gao; Denisha Y Ferguson; Kathleen A Lane; Hugh C Hendrie
Journal:  Ann Intern Med       Date:  2016-11-22       Impact factor: 25.391

9.  Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial.

Authors:  Christopher M Callahan; Malaz A Boustani; Arlene A Schmid; Mary G Austrom; Douglas K Miller; Sujuan Gao; Carrie S Morris; Mickey Vogel; Hugh C Hendrie
Journal:  Trials       Date:  2012-06-27       Impact factor: 2.279

10.  Acute care utilization by dementia caregivers within urban primary care practices.

Authors:  Cathy C Schubert; Malaz Boustani; Christopher M Callahan; Anthony J Perkins; Siu Hui; Hugh C Hendrie
Journal:  J Gen Intern Med       Date:  2008-08-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.